Central venous-to-arterial carbon dioxide difference combined with arterial-to-venous oxygen content difference (PcvaCO2/CavO2) reflects microcirculatory oxygenation alterations in early septic shock

PURPOSE

To explore the relationship between central venous-to-arterial carbon dioxide difference (P_cvaCO₂), P_cvaCO₂/arterial-venous oxygen content difference ratio (P_cvaCO₂/C_avO₂) and the microcirculatory status, evaluated by using near-infrared spectroscopy, in septic shock patients.

METHODS

Observational study in a 30-bed mixed ICU. Fifty septic shock patients within the first 24 h of ICU admission were studied. After restoration of mean arterial pressure, hemodynamic, metabolic and microcirculatory parameters were simultaneously evaluated. Local tissue oxygen saturation (StO₂), and local hemoglobin index (THI) were measured on the thenar eminence by means of near-infrared spectroscopy. A transient vascular occlusion test was performed in order to obtain StO₂ deoxygenation rate (DeO₂), local oxygen consumption (nirVO₂), and reoxgenation rate (ReO₂).

RESULTS

At inclusion, increased P_cvaCO₂ values were associated with lower StO₂ and THI, whereas increased P_cvaCO₂/C_avO₂ values were associated with lower DeO₂, nirVO₂, and ReO₂. Multiple regression models confirmed the association between P_cvaCO₂/C_avO₂ and nirVO₂, while P_cvaCO₂ was only related to CI, and not to microcirculatory parameters.

CONCLUSIONS

In a population of early septic shock patients, increases in P_cvaCO₂ and P_cvaCO₂/C_avO₂ reflected different alterations at the microcirculatory level. While P_cvaCO₂ was related to global flow, the P_cvaCO₂/C_avO₂ ratio was associated to impaired local oxygen utilization and diminished microvascular reactivity.

Respiratory quotient estimations as additional prognostic tools in early septic shock

Central venous-to-arterial carbon dioxide difference (P_cvaCO₂), and its correction by the arterial-to-venous oxygen content difference (P_cvaCO₂/C_avO₂) have been proposed as additional tools to evaluate tissue hypoxia. Since the relationship between pressure and content of CO₂ (CCO₂) might be affected by several factors, some authors advocate for the use of C_cvaCO₂/C_avO₂. The aim of the present study was to explore the factors that might intervene in the difference between P_cvaCO₂/C_avO₂ and C_cvaCO₂/C_avO₂, and to analyze their association with mortality. Observational study in a 30-bed mixed ICU. Fifty-two septic shock patients within the first 24 h of ICU admission were studied. After restoration of mean arterial pressure, hemodynamic and metabolic parameters were evaluated. A total of 110 sets of measurements were performed. Simultaneous P_cvaCO₂/C_avO₂ and C_cvaCO₂/C_avO₂ values were correlated, but agreement analysis showed a significant proportional bias. The difference between P_cvaCO₂/C_avO₂ and C_cvaCO₂/C_avO₂ was independently associated with pH, S_cvO₂, baseline C_cvaCO₂/C_avO₂ and hemoglobin. A stepwise regression analysis showed that pH was the single best predictor for the magnitude of such difference, with very limited effect of other variables. At inclusion, variables associated with ICU-mortality were lactate, pH, P_cvaCO₂/C_avO₂, and the difference between P_cvaCO₂/C_avO₂ and C_cvaCO₂/C_avO₂. Initial S_cvO₂, P_cvaCO₂, C_cvaCO₂/C_avO₂, and cardiac index were not different in survivors and non-survivors. In a population of early septic shock patients, simultaneous values of P_cvaCO₂/C_avO₂ and C_cvaCO₂/C_avO₂ were not equivalent, and the main determinant of the magnitude of the difference between these two parameters was pH. The P_cvaCO₂/C_avO₂ ratio was associated with ICU mortality, whereas C_cvaCO₂/C_avO₂ was not.

Central venous-to-arterial carbon dioxide difference and the effect of venous hyperoxia: A limiting factor, or an additional marker of severity in shock?

Central venous-to-arterial carbon dioxide difference (P_cvaCO₂) has demonstrated its prognostic value in critically ill patients suffering from shock, and current expert recommendations advocate for further resuscitation interventions when P_cvaCO₂ is elevated. P_cvaCO₂ combination with arterial-venous oxygen content difference (P_cvaCO₂/C_avO₂) seems to enhance its performance when assessing anaerobic metabolism. However, the fact that PCO₂ values might be altered by changes in blood O₂ content (the Haldane effect), has been presented as a limitation of PCO₂-derived variables. The present study aimed at exploring the impact of hyperoxia on P_cvaCO₂ and P_cvaCO₂/C_avO₂ during the early phase of shock. Prospective interventional study. Ventilated patients suffering from shock within the first 24 h of ICU admission. Patients requiring FiO₂ ≥ 0.5 were excluded. At inclusion, simultaneous arterial and central venous blood samples were collected. Patients underwent a hyperoxygenation test (5 min of FiO₂ 100%), and arterial and central venous blood samples were repeated. Oxygenation and CO₂ variables were calculated at both time points. Twenty patients were studied. The main cause of shock was septic shock (70%). The hyperoxygenation trial increased oxygenation parameters in arterial and venous blood, whereas PCO₂ only changed at the venous site. Resulting P_cvaCO₂ and P_cvaCO₂/C_avO₂ significantly increased [6.8 (4.9, 8.1) vs. 7.6 (6.7, 8.5) mmHg, p 0.001; and 1.9 (1.4, 2.2) vs. 2.3 (1.8, 3), p < 0.001, respectively]. Baseline P_cvaCO₂, P_cvaCO₂/C_avO₂ and S_cvO₂ correlated with the magnitude of PO₂ augmentation at the venous site within the trial (ρ -0.46, p 0.04; ρ 0.6, p < 0.01; and ρ 0.7, p < 0.001, respectively). Increased P_cvaCO₂/C_avO₂ values were associated with higher mortality in our sample [1.46 (1.21, 1.89) survivors vs. 2.23 (1.86, 2.8) non-survivors, p < 0.01]. P_cvaCO₂ and P_cvaCO₂/C_avO₂ are influenced by oxygenation changes not related to flow. Elevated P_cvaCO₂ and P_cvaCO₂/C_avO₂ values might not only derive from cardiac output inadequacy, but also from venous hyperoxia. Elevated P_cvaCO₂/C_avO₂ values were associated with higher PO₂ transmission to the venous compartment, suggesting higher shunting phenomena.

Evolution over a 15-year period of the clinical characteristics and outcomes of critically ill patients with severe community-acquired pneumonia

OBJECTIVES

To study the characteristics and outcomes of patients in the ICU with severe community-acquired pneumonia (SCAP) over a 15-year surveillance period.

METHODS

We conducted a retrospective cohort study of episodes of SCAP, and assessed the epidemiology, etiology, treatment and outcomes of patients admitted to the ICU, comparing three periods (1999-2003, 2004-2008 and 2009-2013).

RESULTS

A total of 458 patients were diagnosed with SCAP. The overall cumulative incidence was 37.4 episodes/1000 admissions, with a progressive increase over the three periods (P<0.001). Patients fulfilling the two major IDSA/ATS criteria at admission increased from 64.2% in the first period to 82.5% in the last period (P=0.005). Streptococcus pneumoniae was the prevalent pathogen. The incidence of bacteremia was 23.1%, and a progressive significant reduction in overall incidence was observed over the three periods (P=0.02). Globally, 91% of the patients received appropriate empiric antibiotic treatment, increasing from 78.3% in the first period to 97.7% in the last period (P<0.001). Combination antibiotic therapy (betalactam+macrolide or fluoroquinolone) increased significantly from the first period (61%) to the last period (81.3%) (P<0.001). Global ICU mortality was 25.1%, and decreased over the three periods (P=0.001).

CONCLUSIONS

Despite a progressively higher incidence and severity of SCAP in our ICU, crude ICU mortality decreased by 18%. The increased use of combined antibiotic therapy and the decreasing rates of bacteremia were associated to improved patient prognosis.